These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104. Treatment of pulmonary arterial hypertension in children. Latus H; Delhaas T; Schranz D; Apitz C Nat Rev Cardiol; 2015 Apr; 12(4):244-54. PubMed ID: 25645500 [TBL] [Abstract][Full Text] [Related]
105. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Vaillancourt M; Ruffenach G; Meloche J; Bonnet S Can J Cardiol; 2015 Apr; 31(4):407-15. PubMed ID: 25630876 [TBL] [Abstract][Full Text] [Related]
106. Circulating biomarkers in pulmonary arterial hypertension: update and future direction. Pezzuto B; Badagliacca R; Poscia R; Ghio S; D'Alto M; Vitulo P; Mulè M; Albera C; Volterrani M; Fedele F; Vizza CD J Heart Lung Transplant; 2015 Mar; 34(3):282-305. PubMed ID: 25682555 [TBL] [Abstract][Full Text] [Related]
107. Adaptive capacity of the right ventricle: why does it fail? Poels EM; da Costa Martins PA; van Empel VP Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H803-13. PubMed ID: 25681425 [TBL] [Abstract][Full Text] [Related]
108. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension. Stenmark KR; Tuder RM; El Kasmi KC J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027 [TBL] [Abstract][Full Text] [Related]
109. Prognostic Value of Pericardial Effusion on Serial Echocardiograms in Pulmonary Arterial Hypertension. Batal O; Dardari Z; Costabile C; Gorcsan J; Arena VC; Mathier MA Echocardiography; 2015 Oct; 32(10):1471-6. PubMed ID: 25682779 [TBL] [Abstract][Full Text] [Related]
110. Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension. Norman P Expert Opin Ther Pat; 2015 Apr; 25(4):493-9. PubMed ID: 25623274 [TBL] [Abstract][Full Text] [Related]
112. Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension. Motoji Y; Tanaka H; Fukuda Y; Sano H; Ryo K; Imanishi J; Miyoshi T; Sawa T; Mochizuki Y; Matsumoto K; Emoto N; Hirata K Int J Cardiovasc Imaging; 2015 Apr; 31(4):691-8. PubMed ID: 25614330 [TBL] [Abstract][Full Text] [Related]
113. Serious adverse events during a 6-min walk test in patients with pulmonary hypertension. Morris NR; Seale H; Harris J; Hall K; Hopkins P; Kermeen F Eur Respir J; 2015 Apr; 45(4):1179-82. PubMed ID: 25614170 [No Abstract] [Full Text] [Related]
114. Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension. Ambade AS; Naranjo M; Tuhy T; Yu R; Marimoutou M; Everett AD; Shimoda LA; Zimmerman SL; Cubero Salazar IM; Simpson CE; Tedford RJ; Hsu S; Hassoun PM; Damico RL Am J Respir Cell Mol Biol; 2024 Sep; 71(3):343-355. PubMed ID: 38861354 [TBL] [Abstract][Full Text] [Related]
116. Characterization of pulmonary arterial stiffness using cardiac MRI. Cain MT; Schäfer M; Park S; Barker AJ; Vargas D; Stenmark KR; Yu YA; Bull TM; Ivy DD; Hoffman JRH Int J Cardiovasc Imaging; 2024 Feb; 40(2):425-439. PubMed ID: 37902921 [TBL] [Abstract][Full Text] [Related]
117. Human iPSCs as Model Systems for BMP-Related Rare Diseases. Sánchez-Duffhues G; Hiepen C Cells; 2023 Sep; 12(17):. PubMed ID: 37681932 [TBL] [Abstract][Full Text] [Related]
118. Clinical Translation of Engineered Pulmonary Vascular Models. Yuan Y Adv Exp Med Biol; 2023; 1413():273-288. PubMed ID: 37195536 [TBL] [Abstract][Full Text] [Related]
119. New Drugs and Therapies in Pulmonary Arterial Hypertension. Shah AJ; Beckmann T; Vorla M; Kalra DK Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982922 [TBL] [Abstract][Full Text] [Related]